Sell Johnson & Johnson (JNJ) stock to fund a goal
Calculator · free · no signup · JNJNeed cash for a goal? Plan the minimum-tax schedule to sell your vested Johnson & Johnson (JNJ) shares and net a target amount by a target date, across tax years.
Beta · invite-only · AlphaLatitude Inc. · Free Tools
Inputs
Your equity
One stack per ticker (current-employer RSUs, prior-employer holdings, index fund, etc.). Each stack has its own current price, growth assumption, and cost-basis lots.
Drives chance-of-shortfall · default 30%
Lots
Plan
Estimates only. Not financial advice.
Lock-in-now is deterministic (0%). Plans that wait depend on future prices; risk is near-zero when inventory comfortably exceeds the goal. Volatility: each stack's option-implied vol if a ticker is set, otherwise 30%. Lognormal model; real markets have fatter tails.
| Tax | $109,597 | $111,639 | $111,883 | $118,769 |
| Wealth @ target | $719,068 | $716,894 | $714,464 | $712,031 |
| Chance of shortfall | <0.1% | 0% | 1.9% | 3.4% |
Feasible
$400,071 net by 08/01/27
Total tax: $109,597 (federal $58,819, state $36,048, NIIT $14,729)
Schedule · Recommended
| Sale date | Shares | Tax | Net | Cumulative |
|---|---|---|---|---|
| 08/17/26 | 4,085 | $351,104 | $360,043 | |
| 03/31/27 | 4 | $360 | $360,406 | |
| 04/30/27 | 32 | $2,896 | $363,321 | |
| 05/31/27 | 100 | $9,103 | $372,466 | |
| 06/30/27 | 100 | $9,157 | $381,644 | |
| 07/31/27 | 100 | $9,212 | $390,857 | |
| 08/01/27 | 100 | $9,215 | $400,071 |
Risk vs wealth
Each dot is a possible plan. Right is riskier, up is more wealth left over.
Trajectory of cash netted
Solid line = expected. Shaded band = 10th–90th percentile under price uncertainty.
After the plan
You keep 3,479 shares worth $411,873 at the projected target-date price, invested for the next decision.
You solved for a cash target. The beta optimizes your full portfolio across multiple goals and market scenarios, not just one funding need.
Request beta access →Related calculators: RSU Lot Order Calculator · Stock Concentration Calculator · RSU Sell-vs-Hold Calculator
About Johnson & Johnson
Johnson & Johnson (JNJ) is a public Other company, incorporated in New Jersey and headquartered in New Brunswick, NJ.
Equity grants at Johnson & Johnson typically include restricted stock units (RSUs).
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey. The company is ranked No. 48 on the 2025 Fortune 500 list of the largest United States corporations. In 2025, the company was ranked 42nd in the Forbes Global 2000. Along with Microsoft, Johnson & Johnson is one of only two U.S.-based companies that has a prime credit rating of AAA from S&P Global.
Source: Wikipedia (CC BY-SA 4.0)
Founded in New Brunswick, New Jersey in 1886 to make sterile surgical dressings, the company grew into consumer, medical device, and pharmaceutical businesses before separating consumer health as Kenvue in 2023. What remains is Innovative Medicine, with oncology and immunology drugs including Darzalex and Stelara, and MedTech, covering surgery, orthopedics, and cardiovascular devices. Talc litigation over ovarian cancer claims has run for years through repeated bankruptcy-structure attempts. It remains one of few companies rated AAA by major agencies.
Sources: jnj.com · en.wikipedia.org
Equity comp at Johnson & Johnson
- RSUs use single-trigger vesting: shares become yours as each portion vests on schedule, and the value is taxed as ordinary income at that point. No IPO or acquisition is required.
Researched 2026-08-17.
OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by Johnson & Johnson.
If you hold vested Johnson & Johnson (JNJ) shares and need a set amount of cash by a date (a house down payment, tuition, a sabbatical, a business buy-in), the question is which lots to sell and in which tax years to keep the most after tax. This calculator builds the minimum-tax sell schedule across your lots, accounting for federal long-term capital gains, the net investment income tax, and your state.
All Johnson & Johnson tools → · Use the generic Stock Sale Funding Calculator for any company.
Johnson & Johnson equity questions
- How much JNJ stock do I sell to fund a goal without overpaying tax?
- It depends on your cost basis, your target amount and date, and how the sale spreads across tax years. Selling vested JNJ shares triggers long-term capital-gains tax, plus the 3.8% net investment income tax and state tax above certain income, and bunching a large sale into one year can push the gain into a higher bracket. The calculator above builds the minimum-tax sell schedule across your lots to net your target amount by your date.
- Does Johnson & Johnson grant ISOs, NSOs, or RSUs?
- Equity compensation at Johnson & Johnson typically takes the form of restricted stock units (RSUs). Restricted stock units are taxed as ordinary income when they vest.
- Do Johnson & Johnson RSUs use double-trigger vesting?
- No. Johnson & Johnson restricted stock units (RSUs) use single-trigger vesting: each tranche becomes yours as it vests on schedule, taxed as ordinary income at that point, with no liquidity event required.
Find another companyOther peers
- RiverNorth Long Prime Unicorn Fund I, Inc.PublicOpen →
- RiverNorth Short Prime Unicorn Fund I, IncPublicOpen →
- Global X FundsPublicOpen →
- Accenture (ACN)PublicOpen →
- Cognizant (CTSH)PublicOpen →
- Globant (GLOB)PublicOpen →
- DXC Technology (DXC)PublicOpen →
- Eli Lilly (LLY)PublicOpen →
- Pfizer (PFE)PublicOpen →
- Merck (MRK)PublicOpen →
One piece of the puzzle.
OptionsAhoy plans your Johnson & Johnson equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.